to compare between three different volume of ropivacaine and look for pain after surgery

Comparison between three different volumes of fixed concentration of ropivacaine in interscalene brachial plexus block for pain management after arthroscopic shoulder surgery - a randomised control trial - Nil

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/07/071661

Enrollment

Registered

2024-07-31

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Interscalene brachial plexus for postoperative pain management in shoulder arthroscopic surgery: Group A 10 ml of 0.2% ropivacaine through interscalene block and to assess for post ope

Eligibility

Inclusion criteria

Inclusion criteria: ASA I to III BMI 18 to 35 kg/m2

Exclusion criteria

Exclusion criteria: Patient refusal Inability to give consent to study Coagulopathy,sepsis,hepatic or renal failure Patient weight less than 40 kg Pre-existing neuropathy

Design outcomes

Primary

Measure	Time frame
duration of effective analgesia Timepoint: time needed for the need rescue analgesia postoperatively at time interval 0 hours ,2 hours,6 hours,12 hours and 24 hours	—

Secondary

Measure	Time frame
Dose of tramadol needed for effective analgesia Assessment of diaphragm involvementTimepoint: Immediately 24 hours postoperatively	—

Countries

India

Contacts

Public ContactDr venkatesh

Sri Ramachandra medical college and research institute

Venkymail2014@gmail.com9944731220

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026